RecruitingPhase 3NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyCharleston, SC · +147 more sites
RecruitingPhase 3NCT07177352Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesSponsor: Hoffmann-La RocheCharleston, SC · Summerville, SC · +66 more sites
RecruitingPhase 3NCT05511363A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyCharleston, SC · +58 more sites
RecruitingPhase 3NCT06563895Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantSponsor: Eidos Therapeutics, a BridgeBio companyCharleston, SC · Greenville, SC · +38 more sites